908 Devices (MASS) Receivables - Other (2020 - 2021)

908 Devices (MASS) posted quarterly Receivables - Other of $110000.0 for Q3 2021, down 28.57% quarter-over-quarter from $154000.0 in Q2 2021.

908 Devices (MASS) Receivables - Other (2020 - 2021) Analysis & Trends

908 Devices (MASS) has reported Receivables - Other for 2 consecutive years, with $110000.0 the latest figure, recorded in Q3 2021.

In Q3 2021, Receivables - Other changed N/A year-over-year to $110000.0; the TTM figure through Sep 2021 stood at $110000.0 (changed N/A YoY), while the FY2020 annual figure was $47000.0, changed N/A from the prior year.
Receivables - Other declined to $110000.0 in Q3 2021 per MASS's latest filing, from $154000.0 in the prior quarter.
Across five years, Receivables - Other topped out at $154000.0 in Q2 2021 and bottomed at $47000.0 in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	199.24 Bn	193.64 Bn	7.27 Bn
2	Stryker	128.63 Bn	125.15 Bn	4.50 Bn
3	Medtronic	119.19 Bn	109.97 Bn	6.41 Bn
4	Boston Scientific	73.51 Bn	72.97 Bn	3.85 Bn
5	Edwards Lifesciences	52.11 Bn	47.85 Bn	1.35 Bn
6	Dexcom	34.64 Bn	32.70 Bn	830.00 Mn
7	GE HealthCare Technologies	34.01 Bn	31.90 Bn	2.18 Bn
8	Koninklijke Philips	26.40 Bn	23.08 Bn	4.55 Bn
9	Steris	23.14 Bn	22.65 Bn	684.20 Mn
10	908 Devices	389.35 Mn	287.82 Mn	8.34 Mn

Download Data